Clinical Trial Update: The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using Tomotherapy for hypofractionated dose-escalated conformal radiotherapy in high-risk prostate cancer (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN